S. 43In Committee
Skinny Labels, Big Savings Act
Establishes a patent infringement safe harbor for FDA approved skinny labeling of generic and biosimilar drugs under method of use patents
Plain-English overview
What this bill does
Establishes a patent infringement safe harbor for FDA approved skinny labeling of generic and biosimilar drugs under method of use patents
Key points
- Establish patent safe harbor
- Authorize marketing of skinny label drugs
- Allow skinny label approvals
Current status
Where it stands
Status
In Committee
Latest action
2025-01-09 — Read twice and referred to the Committee on the Judiciary.
Related context
Topics and policy areas
undefinedCommerce